KARD vs NKTR: stock comparison and AI forecast
Kardigan, Inc. (KARD) and Nektar Therapeutics (NKTR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KARD Kardigan, Inc.
- Price
- $13.86 -37.2% · 6M
- Market Cap
- $1.30B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NKTR Nektar Therapeutics
- Market Cap
- $1.23B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- KARD and NKTR have similar market capitalizations ($1.30B and $1.23B).
- NKTR carries 0.21 times debt per unit of equity, against 0.17 times for KARD.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KARD | NKTR |
|---|---|---|
| Market Cap | $1.30B | $1.23B |
| P/B Ratio | 2.11x | 1.37x |
| EPS | – | $-6.23 |
| Book Value/Share | $6.58 | $26.45 |
| Revenue/Share | – | $1.60 |
| FCF/Share | – | $-6.85 |
Profitability & Margins
| Metric | KARD | NKTR |
|---|---|---|
| ROE | – | -17.4% |
| ROA | – | -14.3% |
| ROIC | – | -13.7% |
| Operating Margin | – | -257.8% |
| Net Margin | – | -287.8% |
| EBT Margin | – | -287.7% |
| Tax Rate | – | -0.0% |
Financial Health
| Metric | KARD | NKTR |
|---|---|---|
| Current Ratio | 8.72x | 10.42x |
| D/E Ratio | 0.17x | 0.21x |
| Financial Leverage | 1.17x | 1.21x |
| Interest Coverage | – | -120.1x |
| Working Capital | $540M | $668M |
Cash Flow
| Metric | KARD | NKTR |
|---|---|---|
| Operating Cash Flow | – | -$234M |
| Free Cash Flow | – | -$234M |
| Capital Spending | – | -$240K |
| FCF/Sales | – | -428.7% |
| CapEx/Sales | – | 0.5% |
Operational Efficiency
| Metric | KARD | NKTR |
|---|---|---|
| Asset Turnover | – | 0.05x |
Income Statement
| Metric | KARD | NKTR |
|---|---|---|
| Total Revenue | – | $55M |
| Operating Income | – | -$141M |
| Net Income | – | -$157M |
| R&D Expense | – | $132M |
| Cost of Goods Sold | – | $0.00M |
Dividend & Shareholder Information
| Metric | KARD | NKTR |
|---|---|---|
| Shares Outstanding | 94M | 34M |
KARD vs NKTR: stock comparison and AI forecast
Which is bigger, KARD or NKTR?
KARD and NKTR have similar market capitalizations ($1.30B and $1.23B).
Which one does Intratio's AI model rank higher, KARD or NKTR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.